Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Larry Todd Edwards

See Remarks at Arcutis Biotherapeutics, Inc. (ARQT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $968K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 3SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 3,584175,281 held (−2%) $25.16 $90K +5.6%
Mar 3SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 103175,178 held (−0%) $25.91 $3K +2.6%
Feb 4SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 2,052148,865 held (−1%) $25.50 $52K +4.2%
Nov 10SEC ARQTArcutis Biotherapeutics, Inc. Sell 29,131150,193 held (−16%) $25.16 $733K +5.6%
Oct 6SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 4,207178,897 held (−2%) $19.99 $84K +33.0%
Oct 6SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 297179,324 held (−0%) $20.78 $6K +27.9%
  • Sell

    See Remarks Larry Todd Edwards sold $90K of ARQT at $25.16 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Larry Todd Edwards sold $3K of ARQT at $25.91 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Larry Todd Edwards sold $52K of ARQT at $25.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Larry Todd Edwards sold $84K of ARQT at $19.99 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Larry Todd Edwards sold $6K of ARQT at $20.78 — pre-scheduled 10b5-1 plan sale.